BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38679971)

  • 1. Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in Leukemia.
    Pandey S; Singh R; Habib N; Tripathi RM; Kushwaha R; Mahdi AA
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1121-1134. PubMed ID: 38679971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
    Seo J; Yun JE; Kim SJ; Chun YS
    Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target.
    Infantino V; Santarsiero A; Convertini P; Todisco S; Iacobazzi V
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3ζ up-regulates hypoxia-inducible factor-1α in hepatocellular carcinoma via activation of PI3K/Akt/NF-кB signal transduction pathway.
    Tang Y; Lv P; Sun Z; Han L; Luo B; Zhou W
    Int J Clin Exp Pathol; 2015; 8(12):15845-53. PubMed ID: 26884855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
    Huang Y; Chen Z; Lu T; Bi G; Li M; Liang J; Hu Z; Zheng Y; Yin J; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
    J Exp Clin Cancer Res; 2021 Dec; 40(1):398. PubMed ID: 34930376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer Cells.
    Ball AT; Mohammed S; Doigneaux C; Gardner RM; Easton JW; Turner S; Essex JW; Pairaudeau G; Tavassoli A
    J Am Chem Soc; 2024 Apr; 146(13):8877-8886. PubMed ID: 38503564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
    Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
    Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact.
    Rouault-Pierre K; Hamilton A; Bonnet D
    Expert Opin Biol Ther; 2016; 16(4):463-76. PubMed ID: 26679619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the hypoxia-inducible factor pathway protects against acute ischemic stroke by reprogramming central carbon metabolism.
    Madai S; Kilic P; Schmidt RM; Bas-Orth C; Korff T; Büttner M; Klinke G; Poschet G; Marti HH; Kunze R
    Theranostics; 2024; 14(7):2856-2880. PubMed ID: 38773968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual role of MiR-210 in the aetiology of cancer: A focus on hypoxia-inducible factor signalling.
    Afsar S; Syed RU; Bin Break MK; Alsukaybi RH; Alanzi RA; Alshobrmi AM; Alshagdali NM; Alshammari AD; Alharbi FM; Alshammari AM; Algharbi WF; Albrykan KM; Alshammari FN
    Pathol Res Pract; 2024 Jan; 253():155018. PubMed ID: 38070222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia.
    Shohet RV; Garcia JA
    J Mol Med (Berl); 2007 Dec; 85(12):1309-15. PubMed ID: 18026917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypoxia-inducible factor (HIF) couples immunity with metabolism.
    Halligan DN; Murphy SJ; Taylor CT
    Semin Immunol; 2016 Oct; 28(5):469-477. PubMed ID: 27717536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress of hypoxia-inducible factor 1 inhibitors against tumors].
    Niu F; Li Y; Lai FF; Chen XG
    Yao Xue Xue Bao; 2014 Jun; 49(6):832-6. PubMed ID: 25212028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells.
    Befani CD; Vlachostergios PJ; Hatzidaki E; Patrikidou A; Bonanou S; Simos G; Papandreou CN; Liakos P
    J Mol Med (Berl); 2012 Jan; 90(1):45-54. PubMed ID: 21909688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intravenous anesthetic propofol inhibits lipopolysaccharide-induced hypoxia-inducible factor 1 activation and suppresses the glucose metabolism in macrophages.
    Tanaka T; Takabuchi S; Nishi K; Oda S; Wakamatsu T; Daijo H; Fukuda K; Hirota K
    J Anesth; 2010 Feb; 24(1):54-60. PubMed ID: 20039079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway.
    Manolescu B; Oprea E; Busu C; Cercasov C
    Biochimie; 2009; 91(11-12):1347-58. PubMed ID: 19703512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
    Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M
    Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-alpha expression but decrease functional transcriptional activity, DNA binding, and degradation.
    Jones DT; Pugh CW; Wigfield S; Stevens MF; Harris AL
    Clin Cancer Res; 2006 Sep; 12(18):5384-94. PubMed ID: 17000671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.